FDA proposes changes to biological review of medical devices

05/13/2013 | Clinica (subscription required)

The FDA has issued draft guidance intended to help companies prepare regulatory submissions for devices that come into contact with the human body directly or indirectly. The guidance, which is up for comment until July 22, outlines changes to how the international standard ISO-10993 should be used to identify possible toxicity issues tied to those devices.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN